1. Home
  2. CRDO vs IQV Comparison

CRDO vs IQV Comparison

Compare CRDO & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Credo Technology Group Holding Ltd

CRDO

Credo Technology Group Holding Ltd

HOLD

Current Price

$216.70

Market Cap

32.2B

Sector

Technology

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$167.99

Market Cap

28.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRDO
IQV
Founded
2008
1982
Country
Cayman Islands
United States
Employees
N/A
93000
Industry
Semiconductors
Biotechnology: Commercial Physical & Biological Resarch
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.2B
28.6B
IPO Year
2022
2013

Fundamental Metrics

Financial Performance
Metric
CRDO
IQV
Price
$216.70
$167.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
16
Target Price
$179.62
$227.13
AVG Volume (30 Days)
5.2M
1.6M
Earning Date
06-01-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
261.11
4.67
EPS
1.62
1.61
Revenue
$436,775,000.00
$9,739,000,000.00
Revenue This Year
$210.92
$6.77
Revenue Next Year
$57.22
$5.89
P/E Ratio
$119.57
$104.62
Revenue Growth
126.34
41.60
52 Week Low
$59.21
$137.33
52 Week High
$213.80
$247.05

Technical Indicators

Market Signals
Indicator
CRDO
IQV
Relative Strength Index (RSI) 64.41 46.35
Support Level $129.63 $159.08
Resistance Level N/A $172.80
Average True Range (ATR) 17.42 7.14
MACD -0.88 -0.24
Stochastic Oscillator 98.46 44.08

Price Performance

Historical Comparison
CRDO
IQV

About CRDO Credo Technology Group Holding Ltd

Credo Technology Group Holding Ltd delivers high-speed solutions to break bandwidth barriers on every wired connection in the data infrastructure market. It provides secure, high-speed connectivity solutions that deliver improved power and cost efficiency as data rates and corresponding bandwidth requirements increase exponentially throughout the data infrastructure market. It has a geographic presence in Hong Kong, the United States, Mainland China, Taiwan, and the Rest of the World.

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Share on Social Networks: